Stocktoria
ABEONA THERAPEUTICS INC. ABEO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1980-09-19
ABEONA THERAPEUTICS INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.8M | — | $3.5M | $1.4M | $3.0M |
| R&D expense | $26.8M | $34.4M | $31.1M | $29.0M | $38.7M |
| SG&A expense | $65.0M | $29.9M | — | — | — |
| Operating income | -$89.4M | -$64.2M | -$47.1M | -$50.9M | -$89.8M |
| Interest expense | $3.7M | $4.2M | $418,000 | $736,000 | $3.7M |
| Income tax | $100,000 | — | — | — | — |
| Net income | $71.2M | -$63.7M | -$54.2M | -$39.7M | -$84.9M |
| EPS (diluted) | $1.01 | $-1.55 | $-2.53 | $-5.53 | — |
| Operating cash flow | -$76.3M | -$56.0M | -$37.0M | -$43.5M | -$65.7M |
| Free cash flow | -$84.3M | -$58.5M | -$37.3M | -$43.6M | -$69.8M |
| Cash & equivalents | $78.4M | $23.4M | $14.5M | $14.2M | $32.9M |
| Inventory | $5.5M | — | — | — | — |
| Total assets | $219.6M | $108.9M | $64.0M | $64.2M | $79.6M |
| Total liabilities | $60.4M | $64.9M | $49.2M | $37.5M | $37.2M |
| Shareholders' equity | $159.2M | $44.0M | $14.8M | $26.8M | $42.4M |
Source: SEC EDGAR filings · CIK 0000318306 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.